Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dexcom Inc
(NQ:
DXCM
)
74.65
+2.29 (+3.16%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dexcom Inc
< Previous
1
2
...
20
21
22
23
24
25
26
27
Next >
Dexcom Q3 Earnings Beat Street, Raises FY21 Outlook Ahead Of G7 Launch
October 29, 2021
Dexcom Inc's (NASDAQ: DXCM) Q3 adjusted EPS of $0.89 though lower than $0.94 posted a year ago, came in sharply above the consensus of $0.63. Sales increased...
Via
Benzinga
Topics
Earnings
Exposures
Financial
10 Biggest Price Target Changes For Friday
October 29, 2021
Oppenheimer boosted the price target on Apple Inc. (NASDAQ:A...
Via
Benzinga
DexCom Inc (DXCM) Q3 2021 Earnings Call Transcript
October 28, 2021
DXCM earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Recap: DexCom Q3 Earnings
October 28, 2021
DexCom (NASDAQ:DXCM) reported its Q3 earnings results on Thursday, October 28, 2021 at 04:02 PM. Here's what investors need to know about the announcement. Earnings DexCom...
Via
Benzinga
Dexcom Pops Closer To A Record High After Crushing Third-Quarter Forecasts
October 28, 2021
Dexcom easily topped Wall Street's third-quarter forecasts late Thursday.
Via
Investor's Business Daily
Analyst Ratings For DexCom
October 18, 2021
Analysts have provided the following ratings for DexCom (NASDAQ:DXCM) with...
Via
Benzinga
Expert Ratings For DexCom
September 16, 2021
Within the last quarter, DexCom (NASDAQ:DXCM) has observed the following an...
Via
Benzinga
Dexcom Reports Third Quarter 2021 Financial Results
October 28, 2021
From
DexCom, Inc.
Via
Business Wire
2 Unstoppable Stocks to Buy and Hold for Decades
October 21, 2021
These are investments that you won't need to worry about.
Via
The Motley Fool
Dexcom Schedules Third Quarter 2021 Earnings Release and Conference Call for October 28, 2021 at 4:30 p.m. Eastern Time
October 05, 2021
From
Dexcom, Inc.
Via
Business Wire
1 Supercharged Healthcare Stock to Buy Right Now
September 29, 2021
The stock isn't a household name, but it's generated multibagger returns over the past five years alone.
Via
The Motley Fool
Ignore GameStop: Here Are 2 Better Stocks
September 28, 2021
The performance of these two companies isn't detached from their financial results.
Via
The Motley Fool
Exposures
COVID-19
Dexcom Insider Sold Over $3.87 Million In Company Stock
September 27, 2021
Steven R Pacelli, Managing Dir. And Dexcom Ventures at Dexcom (NASDAQ:DXCM), made a large insider sell on September 23, according to a new SEC filing. What Happened: A Form 4...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Desperate for Solutions, Diabetes and Obesity Healthcare Sectors Find Answers, Hope in Innovative Tech
September 23, 2021
Via
Investor Brand Network
Exposures
COVID-19
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
September 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22) Acceleron Pharma Inc. (...
Via
Benzinga
Exposures
COVID-19
Dexcom Insider Sold Over $3.24 Million In Company Stock
September 17, 2021
Kevin R Sayer, CEO And President at Dexcom (NASDAQ:DXCM), made a large insider sell on September 15, according to a new SEC filing. What Happened: A Form 4 filing from the U.S....
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Notable Dexcom Insider Makes $3.06 Million Sale
September 14, 2021
Andrew K Balo, * at Dexcom (NASDAQ:DXCM), made a large insider sell on September 9, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold
September 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Bicycle Therapeutics plc (...
Via
Benzinga
Non-insured Health Benefits Program Now Covers Dexcom G6 Continuous Glucose Monitoring System for Children and Adolescents on Intensive Insulin Therapy
September 13, 2021
From
Dexcom, Inc.
Via
Business Wire
Notable Dexcom Insider Makes $10.22 Million Sale
September 10, 2021
Quentin S Blackford, Chief Operating Officer at Dexcom (NASDAQ:DXCM), made a large insider sell on September 10, according to a new SEC filing. What Happened: A Form 4 filing...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
September 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (...
Via
Benzinga
This Smart Monitor Company Has Outperformed Apple, Google And Amazon Over The Last 5 Years
September 08, 2021
A smart monitor company that received FDA approval in 2015 has seen a five-year stock performance that has outperformed the returns of Apple Inc (NASDAQ: AAPL), Alphabet Inc (...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
September 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...
Via
Benzinga
Exposures
COVID-19
Dexcom Announces Upcoming Virtual Conference Presentations
September 02, 2021
From
DexCom, Inc.
Via
Business Wire
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...
Via
Benzinga
Moderna And DexCom Lead The Nasdaq-100
September 01, 2021
U.S. indices had a mixed day of trading Wednesday as investors weigh rising COVID-19 Delta variant cases nationwide. The Invesco QQQ Trust Series 1 (NASDAQ: QQQ) gained 0.17% to...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...
Via
Benzinga
Exposures
COVID-19
Product Safety
Pool, Dexcom Lead Five Stocks Showing Tight, Bullish Action Near Buy Points
August 28, 2021
Tight trading is a bullish sign. Pool, Dexcom lead five stocks trading tightly near buy points.
Via
Investor's Business Daily
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU...
Via
Benzinga
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
< Previous
1
2
...
20
21
22
23
24
25
26
27
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.